Search

everythinglearnresearchcommunity

for

Search:↓

Warming hands improves blood flow in people with systemic sclerosis.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Severe allergic reactions to hair dye can trigger hair loss and may be linked to multiple sclerosis.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Ectodin integrates BMP, SHH, and FGF signals in developing ectodermal organs.

Laser hair removal significantly improves acne keloidalis nuchae, especially with early treatment.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

Cannabinoids may help treat various skin conditions.

Eczema and fungal infections are the most common skin problems in Japan, with different age groups and genders affected by various conditions.

Poliosis circumscripta is a patch of white hair caused by lack of melanin, linked to genetic and acquired conditions.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

MicroRNA-21 could help diagnose and treat skin fibrosis.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Cannabinoids might help with skin diseases and hair growth, but more research is needed.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Nail loss may be a side effect of the MS drug teriflunomide.

Cannabinoids may help some skin conditions but more research is needed.

Histone modification is key in treating chronic inflammatory skin diseases.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.